Understanding the symptoms experienced by individuals with lung cancer

Kiteley, Catherine; Fitch, Margaret I.

doi:10.5737/1181912x1612530

Cited by 10 publications

(8 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…[45,49] Given the heterogeneous nature of the studies, this finding suggests that nocturia is a symptom that has been infrequently assessed, but which necessitates further systematic evaluation and consideration as a symptom to assess in a broad range of cancers. Similar arguments can be made for sexual dysfunction[45,51] and cough[45,46,48,51,53] which each were reported by patients in disparate studies (nation, cancer site, sample sizes) as highly prevalent and of moderate to high severity.…”

Section: Discussionmentioning

confidence: 67%

A literature synthesis of symptom prevalence and severity in persons receiving active cancer treatment

Reilly

Bruner

Mitchell

et al. 2013

Support Care Cancer

266

214

View full text Add to dashboard Cite

Purpose Patients with cancer experience acute and chronic symptoms caused by their underlying disease or by the treatment. While numerous studies have examined the impact of various treatments on symptoms experienced by cancer patients, there are inconsistencies regarding the symptoms measured and reported in treatment trials. This article presents a systematic review of the research literature of the prevalence and severity of symptoms in patients undergoing cancer treatment. Methods A systematic search for studies of persons receiving active cancer treatment was performed with the search terms of “multiple symptoms” and “cancer” for studies involving patients over the age of 18 years and published in English during the years 2001 to 2011. Search outputs were reviewed independently by seven authors, resulting in the synthesis of 21 studies meeting criteria for generation of an Evidence Table reporting symptom prevalence and severity ratings. Results Data were extracted from 21 multi-national studies to develop a pooled sample of 4067 cancer patients in whom the prevalence and severity of individual symptoms was reported. In total, the pooled sample across the 21 studies was comprised of 62% female, with a mean age of 58 years (range: 18 to 97 years). A majority (62%) of these studies assessed symptoms in homogeneous samples with respect to tumor site (predominantly breast and lung cancer), while 38% of the included studies utilized samples with mixed diagnoses and treatment regimens. Eighteen instruments and structured interviews were including those measuring single symptoms, multi-symptom inventories, and single symptom items drawn from HRQOL or health status measures. The MD Anderson Symptom Inventory (MDASI) was the most commonly used instrument in the studies analyzed (n=9 studies; 43%), while the Functional Assessment of Cancer Therapy (FACT-G), Hospital Anxiety and Depression Subscale (HADS-D), Medical Outcomes Survey Short Form-36 (SF-36), and Symptom Distress Scale (SDS) were each employed in two studies. Forty-seven symptoms were identified across the 21 studies which were then categorized into 17 logical groupings. Symptom prevalence and severity were calculated across the entire cohort and also based upon sample sizes in which the symptoms were measured providing the ability to rank symptoms. Conclusions Symptoms are prevalent and severe among patients with cancer. Therefore, any clinical study seeking to evaluate the impact of treatment on patients should consider including measurement of symptoms. This study demonstrates that a discrete set of symptoms is common across cancer types. This set may serve as the basis for defining a “core” set of symptoms to be recommended for elicitation across cancer clinical trials, particularly among patients with advanced disease.

show abstract

Section: Discussionmentioning

confidence: 67%

A literature synthesis of symptom prevalence and severity in persons receiving active cancer treatment

Reilly

Bruner

Mitchell

et al. 2013

Support Care Cancer

266

214

View full text Add to dashboard Cite

show abstract

“…In a recent study designed to better understand the symptom experience of individuals with lung cancer, fatigue and pain were the most frequently identified symptoms. However, the study also emphasized that patients were dealing with several symptoms at one time (Kiteley & Fitch, 2006).…”

Section: Literature Reviewmentioning

confidence: 99%

“…Dealing with the consequences of lung cancer and its treatment can be taxing for the person and his or her family (Kiteley & Fitch, 2006). While some people, given appropriate information and therapeutic relationships with the cancer care team, are able to mobilize their own resources to cope with their cancer experiences, others require additional assistance.…”

Section: Besoinsmentioning

confidence: 99%

Supportive care needs of individuals with lung cancer

Fitch¹,

Steele²

2010

CONJ

Self Cite

View full text Add to dashboard Cite

“…On doit également tenir compte des symptômes qui sont regroupés ou qui peuvent survenir ensemble. Pour le patient, les symptômes sont le plus souvent vécus et éprouvés simultanément et non isolément (Kiteley et Fitch, 2006;Kim et al, 2009). Il serait utile que des interventions soient élaborées pour répondre de manière appropriée à des combinaisons de symptômes et non pas à un seul symptôme ou à un symptôme considéré de manière isolée.…”

Section: Discussionunclassified

Besoins en soins de soutien non comblés et désir de recevoir de l’aide de patients recevant de la radiothérapie : répercussions sur l’infirmière en oncologie

Fitch

Maamoun

2016

CONJ

View full text Add to dashboard Cite

Les besoins en soins de soutien non comblés peuvent contribuer à la détresse psychologique et réduire la qualité de vie des patients atteints de cancer. Nous avons effectué une évaluation des besoins en soins de soutien chez les patients qui recevaient de la radiothérapie pour la planification d'un programme. Un questionnaire d'auto-évaluation des besoins en soins de soutien a été rempli par un échantillon de convenance de 115 patients les jours 5, 7 et 16 de leur radiothérapie. Les besoins physiques non comblés les plus nommés les trois fois étaient la fatigue (33-49 %), une peau sèche prurigineuse (24-37 %) et les troubles du sommeil (23-30 %). Le nombre de patients mentionnant ces besoins non comblés a considérablement augmenté au cours de l'étude. Sur le plan psychologique, l'inquiétude (34,5 %) arrivait en tête le jour 5. Le nombre de personnes exprimant de l'inquiétude n'a pas vraiment diminué avant le jour 16. Dans tous les domaines et pour tous les éléments individuels, il y avait une grande variation du pourcentage de patients qui avaient des besoins non comblés et qui ont indiqué vouloir de l'aide concernant ces mêmes besoins. Ce modèle est resté cohérent au fil du temps. Cette étude fait ressortir le besoin de se doter d'un processus défini ou intentionnel pour évaluer les besoins en soins de soutien et le désir du patient d'obtenir de l'assistance ou de l'aide pour combler ses besoins. Note : La coordination de la révision par les pairs pour cet article a été effectuée par l'ancien rédacteur en chef de la Revue.

show abstract

Understanding the symptoms experienced by individuals with lung cancer

Abstract: The author has granted a nonexclusive licence allowing the National Library of Canada to reproduce, loan, distribute or sell copies of this thesis in microform, paper or electronic formats.

Cited by 10 publications

References 13 publications

A literature synthesis of symptom prevalence and severity in persons receiving active cancer treatment

A literature synthesis of symptom prevalence and severity in persons receiving active cancer treatment

Supportive care needs of individuals with lung cancer

Besoins en soins de soutien non comblés et désir de recevoir de l’aide de patients recevant de la radiothérapie : répercussions sur l’infirmière en oncologie

Contact Info

Product

Resources

About